A 15-year-old girl with recurrent right otitis media now has persistent ear fullness and drainage after the acute infection resolved; what is the appropriate management?

Management of Persistent Ear Drainage and Fullness After Recurrent Otitis Media

This 15-year-old girl with persistent ear drainage and fullness after recent infection should be treated with topical quinolone antibiotic ear drops (with or without steroid) as first-line therapy, which is superior to oral antibiotics for achieving clinical cure.

Immediate Management

First-Line Treatment: Topical Antibiotic Therapy

• Prescribe topical quinolone ear drops (such as ofloxacin or ciprofloxacin, with or without steroid) for up to 10 days 1
• Topical antibiotics achieve clinical cure rates of 77-96% compared to only 30-67% with oral antibiotics 1
• The superior efficacy results from increased drug concentration at the infection site (up to 1000 times higher than systemic levels) and improved coverage of likely pathogens, especially Pseudomonas aeruginosa 1

Critical Pre-Treatment Step: Ear Canal Cleaning

• Clean the ear canal of debris and discharge before administering drops to ensure medication reaches the middle ear space 1
• Use tissue spears (twisted facial tissue) to absorb drainage from the external canal, or have caregivers gently blot the canal opening 1
• An infant nasal aspirator can gently suction visible secretions 1

Important Safety Consideration

• Only use quinolone drops approved for middle ear use—avoid aminoglycoside-containing drops (typically used for otitis externa) due to potential ototoxicity 1
• Topical quinolones are safe in children despite systemic quinolones not being approved for those under 14 years, because topical drops are not absorbed systemically 1

If Initial Treatment Fails

Second-Line Interventions (4-8% of cases)

• If symptoms persist after topical therapy, the patient may require professional ear canal cleaning or suctioning to facilitate drug delivery 1
• Obtain culture of persistent drainage to identify resistant organisms such as fungi or methicillin-resistant Staphylococcus aureus (MRSA) 1
• Even if culture shows quinolone resistance based on serum levels, topical treatment often succeeds due to the concentration-dependent bactericidal effect of high local antibiotic levels 1

Oral Antibiotic Rescue

• Reserve oral antibiotics for the 4-8% of patients who fail topical therapy 1
• Guide antibiotic selection by culture results 1
• Systemic antibiotics carry risks of dermatitis, allergic reactions, gastrointestinal upset, oral thrush, and increased antibiotic resistance 1

Evaluation for Underlying Conditions

Assess for Otitis Media with Effusion (OME)

• The persistent ear fullness suggests possible middle ear effusion that may remain after the acute infection resolved 2
• Perform pneumatic otoscopy to document middle ear effusion 3
• If pneumatic otoscopy is uncertain or difficult, obtain tympanometry for objective confirmation 3

Hearing Assessment

• If effusion persists for 3 months or longer, obtain age-appropriate hearing testing 3
• This is particularly important given her history of recurrent infections, which increases risk for persistent effusion 2

Common Pitfalls to Avoid

• Do not prescribe oral antibiotics as first-line therapy for ear drainage—this is less effective and carries more adverse effects 1
• Do not use aminoglycoside ear drops (such as neomycin-containing preparations) due to ototoxicity risk 1
• Do not limit topical therapy to less than adequate duration, but also advise caregivers not to exceed 10 days to avoid complications like otomycosis 1
• Do not assume treatment failure without first ensuring proper ear canal cleaning—debris obstruction is a common cause of apparent treatment resistance 1

Patient and Family Education

• Counsel the patient and family that most ear drainage responds rapidly to topical antibiotics when drops can reach the middle ear 1
• Explain the importance of ear canal cleaning before drop administration 1
• Discuss the natural history and need for follow-up if fullness persists beyond treatment completion 3